Vitamin D may be of interest in the prevention of cognitive impairment, though previous findings are inconclusive. Participants were 1766 adults aged 65 years and older from the Health Survey for England 2000, a nationally representative population-based study. Cognitive impairment was assessed using the Abbreviated Mental Test Score. The cross-sectional relation of serum 25-hydroxyvitamin D quartiles to cognitive impairment was modeled using logistic regression. In all, 212 participants (12%) were cognitively impaired. Odds ratios (95% confidence intervals) for cognitive impairment in the first (8-30 nmol/L), second (31-44 nmol/L), and third (45-65 nmol/L) quartiles of serum 25-hydroxyvitamin D compared with the fourth (66-170 nmol/L) were 2.3 (1.4-3.8), 1.4 (0.8-2.4), and 1.1 (0.6-1.9), after adjustment for age, sex, education, ethnicity, season of testing, and additional risk factors for cognitive impairment (P for linear trend = .001). Our data suggest low serum 25-hydroxyvitamin D is associated with increased odds of cognitive impairment.
van der Wielen RP, Lowik MR, van den Berg H., et al. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346:207-210.
2.
Autier P., Gandini S.Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730-1737.
3.
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E., Dietrich T., Dawson-Hughes B.Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293: 2257-2264.
4.
Palomer X., Gonzalez-Clemente JM, Blanco-Vaca F., Mauricio D.Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185-197.
5.
McCann JC , Ames BNIs there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008;22:982-1001.
6.
Garcion E., Wion-Barbot N., Montero-Menei CN, Berger F., Wion D.New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100-105.
7.
Bourre JMEffects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006;10:377-385.
8.
Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148:427-434.
9.
Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demo-graphics, and memory study. Neuroepidemiology. 2007;29:125-132.
10.
Heaney RPFunctional indices of vitamin D status and ramifications of vitamin D deficiency . Am J Clin Nutr. 2004;80(suppl 6):1706S-1709S.
11.
Kipen E., Helme RD, Wark JD, Flicker L.Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc. 1995;43: 1088-1091.
12.
Sato Y., Honda Y., Hayashida N., Iwamoto J., Kanoko T., Satoh K.Vitamin K deficiency and osteopenia in elderly women with Alzheimer’s disease. Arch Phys Med Rehabil. 2005;86:576-581.
13.
Nes M., Sem SW, Rousseau B., et al. Dietary intakes and nutritional status of old people with dementia living at home in Oslo. Eur J Clin Nutr. 1988 ;42:581-593.
14.
Oudshoorn C. , Mattace-Raso FU, van der Velde N., Colin EM, van der Cammen TJHigher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord . 2008;25:539-543.
15.
Przybelski RJ, Binkley NCIs vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007;460:202-205.
16.
Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JCVitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14:1032-1040.
17.
Aung K., Burnett J., Smith SM, Dyer CBVitamin D deficiency associated with self-neglect in the elderly. J Elder Abuse Negl. 2006;18:63-78.
18.
Jorde R., Waterloo K., Saleh F., Haug E., Svartberg J.Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol. 2006;253:464-470.
19.
McGrath J., Scragg R., Chant D., Eyles D., Burne T., Obradovic D.No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology. 2007;29: 49-54.
20.
Dhesi JK, Jackson SH, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004;33:589-595.
21.
Przybelski R. , Agrawal S., Krueger D., Engelke JA, Walbrun F., Binkley N.Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int. 2008 ;19:1621-1628.
22.
Prior G., Teers R., Brookes M., Primatesta P.Health Survey for England 2000: Methodology and Documentation. London: The Stationery Office; 2002.
23.
Hodkinson HMEvaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1:233-238.
24.
Jitapunkul S., Pillay I., Ebrahim S.The abbreviated mental test: its use and validity . Age Ageing. 1991;20:332-336.
25.
Stewart R., Hirani V.Dental health and cognitive impairment in an English national survey population . J Am Geriatr Soc. 2007;55:1410-1414.
26.
Iseli RK, Brand C., Telford M., LoGiudice D.Delirium in elderly general medical inpatients: a prospective study. Intern Med J. 2007;37:806-811.
27.
Flicker L., Logiudice D., Carlin JB, Ames D.The predictive value of dementia screening instruments in clinical populations . Int J Geriatr Psychiatry. 1997;12:203-209.
28.
Hendrie HC, Albert MS, Butters MA, et al. The NIH Cognitive and Emotional Health Project: Report of the Critical Evaluation Study Committee. Alzheimer’s & Dementia. 2006;2:12-32.
29.
Goldberg D., Williams P.A User’s Guide to the General Health Questionnaire. Windsor, Berkshire: NFER-NELSON; 1988.
30.
Scragg R., Holdaway I., Jackson R., Lim T.Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol. 1992;2:697-703.
31.
Zuccala G., Marzetti E., Cesari M., et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med. 2005;118: 496-502.
32.
Wortsman J. , Matsuoka LY, Chen TC, Lu Z., Holick MFDecreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-693.
33.
Holick MFVitamin D deficiency. N Engl J Med. 2007;357:266-281.
34.
Feldman H., Clarfield AM, Brodsky J., King Y., Dwolatzky T.An estimate of the prevalence of dementia among residents of long-term care geriatric institutions in the Jerusalem area. Int Psychogeriatr . 2006;18: 643-652.
35.
Matthews FE , Dening T.Prevalence of dementia in institutional care . Lancet. 2002;360:225-226.
36.
Eyles DW, Smith S., Kinobe R., Hewison M., McGrath JJDistribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain . J Chem Neuroanat. 2005;29: 21-30.
37.
Ibi M., Sawada H., Nakanishi M., et al. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology. 2001;40:761-771.
38.
Kalueff AV, Eremin KO, Tuohimaa P.Mechanisms of neuroprotective action of vitamin D(3). Biochemistry (Mosc). 2004;69:738-741.
39.
Brown J., Bianco JI, McGrath JJ, Eyles DW1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 2003;343:139-143.
40.
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A.Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832-2838.
41.
Newmark HL, Newmark J.Vitamin D and Parkinson’s disease-a hypothesis. Mov Disord. 2007;22:461-468.
42.
Kasa M., Bierma TJ, Waterstraat F. Jr, Corsaut M., Singh SPRoutine blood chemistry screen: a diagnostic aid for Alzheimer’s disease . Neuroepidemiology. 1989;8: 254-261.
